Carboxypeptidase N1 (CPN1) Antibody
357.5€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Carboxypeptidase N1 (CPN1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx145290
tested applications
ELISA, WB, IHC
Description
CPN1 Antibody is a Rabbit Polyclonal against CPN1.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Target: Carboxypeptidase N1 (CPN1) Immunogen: Recombinant fragment corresponding to 160-327 AA of human CPN1. |
| Host | Rabbit |
| Reactivity | Human |
| Assay Type | Concentration: Lyophilized form: Not applicable. After reconstitution: 1 mg/ml. |
| Recommended Dilution | ELISA: 1/20000 - 1/80000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Observed MW | Observed MW: 52 kDa |
| Purification | Purified by antigen affinity column chromatography. |
| Size 1 | 100 µg |
| Size 2 | 1 mg |
| Form | Lyophilized |
| Tested Applications | ELISA, WB, IHC |
| Buffer | Prior to lyophilization: 1% BSA and 0.02% NaN3. |
| Availability | Shipped within 7-15 working days. |
| Storage | Store at -20 °C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| NCBI Accession | BC027897 |
| Alias | Anaphylatoxin inactivator,Arginine carboxypeptidase |
| Background | Antibody anti-CPN1 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Descripción
Related Products
Human CPN1 (Carboxypeptidase N catalytic chain) ELISA Kit
Ver Producto
CPN1 antibody
Protects the body from potent vasoactive and inflammatory peptides containing C-terminal Arg or Lys(such as kinins or anaphylatoxins) which are released into the circulation.
Ver ProductoCPN1 antibody
Protects the body from potent vasoactive and inflammatory peptides containing C-terminal Arg or Lys(such as kinins or anaphylatoxins) which are released into the circulation.
Ver Producto